Indinavir + Segesterone Acetate And Ethinyl Estradiol Interaction
Unknowninteraction on record
Description
In contrast, significant increases in systemic exposure of estrogen and/or progestin have been noted when CHCs are co-administered with certain other HIV protease inhibitors (eg, indinavir and atazanavir/ritonavir) and with other non-nucleoside reverse transcriptase inhibitors (eg, etravirine).
Source: FDA drug label - segesterone acetate and ethinyl estradiol